You Searched For "molnupiravir" and got 18 results
Sort By:
2 mins read
Sun Pharma gets emergency use authorization to manufacture Merck's anti-Covid pill Molnupiravir
Amid the ongoing resurgence of new Covid-19 cases in India, an expert panel of the Central Dru…
2 mins read
ICMR experts reject inclusion of Molnupiravir in COVID-19 treatment guidelines for fourth time citing safety concerns
Responding to a question over Molnupiravir's inclusion in the treatment guidelines amid doctors …
PTI
2 mins read
Merck jumps 10% as the drugmaker says its antiviral pill cuts the risk of hospitalizations and deaths in COVID patients
Merck already has a deal to supply 1.7 million courses of antiviral pill molnupiravir to the US gov…
Carla Mozée
1 min read
Merck says it'll ask regulators to authorize the first antiviral pill designed to treat COVID-19 after a trial found it halved the risk of hospitalization or death
Merck and Ridgeback on Friday morning said they'd apply for emergency FDA authorization for the dru…
Grace Dean
1 min read
A new pill designed to treat active COVID-19 infections was just approved by the UK, the first country to do so
Early trial results found that Merck's molnupiravir, the first antiviral designed to treat COVID-19…
Mary Hanbury
4 mins read
Sun Pharma, Dr Reddy’s Lab, Divi’s Lab and other pharma stocks rally on regulator’s nod to make anti-COVID pill
Pharmaceutical company stocks were the top gainers in a weak market on December 29 as the segment c…
4 mins read
Merck is set to make billions off a COVID-19 pill that could change the pandemic. Here's why some countries will pay more than others.
Merck's antiviral has not yet been authorized, but the company already has plans to distribute the …
Andrew Dunn
1 min read
Merck requests FDA authorization for its anti-COVID-19 pill, the next step towards rolling it out
The pill "significantly reduced the risk of hospitalization or death," according to the developers …
Marianne Guenot
1 min read
Retail investors are dumping shares of COVID-19 vaccine makers and piling into antiviral pill maker Merck, data shows
Merck shares have jumped since the drug maker said molnupiravir cuts the risk of COVID hospitalizat…
Carla Mozée
1 min read
Top Stories this PM: Merck requests authorization for anti-COVID pill; Facebook Oversight Board to meet with whistleblower
If authorized, the drug, called molnupiravir, would become the first oral antiviral treatment for C…
INSIDER
4 mins read
An FDA expert panel narrowly supports the first COVID-19 pill but suggests restrictions on its use driven by safety concerns
A COVID-19 pill could prevent infected people from getting seriously sick. But the FDA panel expres…
Andrew Dunn,Andrea Michelson
3 mins read
'An extraordinary effect': Pfizer says its COVID-19 pill reduced the risk of hospitalization and death by 89% in high-risk patients
"Our ability to stop living in fear is now within reach," Mikael Dolsten, Pfizer's chief scientific…
Andrew Dunn
6 mins read
A COVID-19 pill could soon fill a gap in our pandemic response that vaccines can’t overcome
Antivirals that can be taken orally are "one more piece of the larger puzzle of solving the COVID p…
Andrew Dunn
4 mins read
New COVID-19 drug claims it can suppress transmission within 24 hours
Even as the world cheers the progress being made on several vaccines to protect against the Covid-1…
3 mins read
Blood pressure drug ineffective in treating even mild Covid-19 cases, as per 'real world' data from India
A drug used to treat high blood pressure was found to be ineffective in treating even mild COVID-19…
PTI
2 mins read
Dogecoin, Merck's antiviral pill, and Nicole Kidman: Here's what AMC CEO and meme-stock icon Adam Aron has been talking about
The AMC chief executive caught the attention of Tesla's Elon Musk and billionaire investor Mark Cub…
Natasha Dailey
1 min read
Pfizer soars 11% on strong results from COVID-19 pill study, while Moderna and Merck tumble
Pfizer plans to seek the Food and Drug Administration's OK this month for the pill, with doses pote…
Phil Rosen
1 min read
Sensex surges 500 points; shares of Eicher Motors, L&T, Asian Paints, automobile, IT companies among top gainers
In the previous session, the 30-share equity benchmark settled 295.93 points or 0.52 per ce…